Blood Cancer Journal

SJR Rank #386H-index: 94SJR: 4.307Best quartile: Q1Open AccessAPC: US$5,290Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Springer Nature

Country

United Kingdom

Type

journal

SJR by Edition

2022202502468

Subject Categories

  • HematologyQ1
  • OncologyQ1

Areas: Medicine

Most published research topics

Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentProtein Degradation and InhibitorsChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchHematopoietic Stem Cell Transplantation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025055110165220

Detailed Information

ISSN

2044-5385

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

6.92

References per Document

25.50

Coverage

2011-2026

Scope

Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. Topics of particular interest include, but are not limited to, the following: Preclinical studies of new compounds, especially those that provide mechanistic insights Clinical trials and observations Reviews related to new drugs and current management of hematologic malignancies Novel observations related to new mutations, molecular pathways, and tumor genomics.

Metrics from SCImago Journal Rank 2025. View on SCImago